Serum WFA-sialylated MUC1 levels in BTC/IhCC varied little by pathological cancer stage or tumor tissue type, with similar levels between early and advanced stages and between well-differentiated and undifferentiated carcinomas. This evidence concerns the gene MUC1 and carcinoma.